{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:30:24Z","timestamp":1775817024897,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40272-022-00495-1","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T02:02:48Z","timestamp":1646100168000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and Costs of Three Pharmacotherapies for Patent Ductus Arteriosus Closure in Premature Infants"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1476-7619","authenticated-orcid":false,"given":"Ramesh","family":"Vidavalur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"issue":"1","key":"495_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/children8010047","volume":"8","author":"A Smith","year":"2021","unstructured":"Smith A, El-Khuffash A. Patent ductus arteriosus clinical trials: lessons learned and future directions. Children (Basel, Switzerland). 2021;8(1):47. https:\/\/doi.org\/10.3390\/children8010047.","journal-title":"Children (Basel, Switzerland)"},{"issue":"1","key":"495_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jsha.2010.03.002","volume":"22","author":"S Ghanem","year":"2010","unstructured":"Ghanem S, Mostafa M, Shafee M. Effect of oral ibuprofen on patent ductus arteriosus in premature newborns. J Saudi Heart Assoc. 2010;22(1):7\u201312. https:\/\/doi.org\/10.1016\/j.jsha.2010.03.002.","journal-title":"J Saudi Heart Assoc"},{"issue":"4","key":"495_CR3","doi-asserted-by":"publisher","first-page":"F279","DOI":"10.1136\/archdischild-2011-300532","volume":"97","author":"O Erdeve","year":"2012","unstructured":"Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, Oguz SS, Uras N. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2012;97(4):F279\u201383. https:\/\/doi.org\/10.1136\/archdischild-2011-300532.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9","key":"495_CR4","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s12272-012-0919-8","volume":"35","author":"MJ Heo","year":"2012","unstructured":"Heo MJ, Lee OS, Lim SC. Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus. Arch Pharmacal Res. 2012;35(9):1673\u201383. https:\/\/doi.org\/10.1007\/s12272-012-0919-8.","journal-title":"Arch Pharmacal Res"},{"issue":"4","key":"495_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jpeds.2010.10.008","volume":"158","author":"T Gokmen","year":"2011","unstructured":"Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr. 2011;158(4):549-554.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2010.10.008.","journal-title":"J Pediatr"},{"key":"495_CR6","doi-asserted-by":"publisher","first-page":"CD003745","DOI":"10.1002\/14651858.CD003745","volume":"2","author":"L Cooke","year":"2003","unstructured":"Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2003;2:CD003745. https:\/\/doi.org\/10.1002\/14651858.CD003745.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"495_CR7","doi-asserted-by":"publisher","first-page":"F99","DOI":"10.1136\/archdischild-2013-304695","volume":"99","author":"M Kluckow","year":"2014","unstructured":"Kluckow M, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2014;99(2):F99\u2013104. https:\/\/doi.org\/10.1136\/archdischild-2013-304695.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"495_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003481.pub8","volume":"2","author":"A Ohlsson","year":"2020","unstructured":"Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (Or both) infants. Cochrane Database Syst Rev. 2020;2: CD003481. https:\/\/doi.org\/10.1002\/14651858.CD003481.pub8.","journal-title":"Cochrane Database Syst Rev"},{"key":"495_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013133.pub2","volume":"1","author":"P Evans","year":"2021","unstructured":"Evans P, O\u2019Reilly D, Flyer JN, Soll R, Mitra S. Indomethacin for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2021;1: CD013133. https:\/\/doi.org\/10.1002\/14651858.CD013133.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"495_CR10","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jama.2018.1896","volume":"319","author":"S Mitra","year":"2018","unstructured":"Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, Zea AM, Zhang Y, Sadeghirad B, Thabane L. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA. 2018;319(12):1221\u201338. https:\/\/doi.org\/10.1001\/jama.2018.1896.","journal-title":"JAMA"},{"issue":"6","key":"495_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/jp.2010.49","volume":"30","author":"A Sehgal","year":"2010","unstructured":"Sehgal A. Global shortage and rationing of indomethacin: need to refine approach. J Perinatol. 2010;30(6):384\u20137. https:\/\/doi.org\/10.1038\/jp.2010.49.","journal-title":"J Perinatol"},{"issue":"3","key":"495_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00431-020-03780-8","volume":"180","author":"C Dani","year":"2021","unstructured":"Dani C, Lista G, Bianchi S, Mosca F, Schena F, Ramenghi L, Zecca E, Vento G, Poggi C, Leonardi V, Minghetti D, Rosignoli MT, Calisti F, Comandini A, Cattaneo A, Lipone P. Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial. Eur J Pediatr. 2021;180(3):807\u201316. https:\/\/doi.org\/10.1007\/s00431-020-03780-8.","journal-title":"Eur J Pediatr"},{"key":"495_CR13","doi-asserted-by":"publisher","first-page":"CD010061","DOI":"10.1002\/14651858.CD010061.pub4","volume":"1","author":"A Ohlsson","year":"2020","unstructured":"Ohlsson A, Shah PS. Paracetamol (Acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2020;1:CD010061. https:\/\/doi.org\/10.1002\/14651858.CD010061.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"495_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, Moher D, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"495_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, Higgins JPT. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical Research Ed). 2019;366: l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"21","key":"495_CR16","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1080\/14767058.2018.1470235","volume":"32","author":"RA El-Farrash","year":"2019","unstructured":"El-Farrash RA, El Shimy MS, El-Sakka AS, Ahmed MG, Abdel-Moez DG. Efficacy and safety of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Matern Fetal Neonatal Med. 2019;32(21):3647\u201354. https:\/\/doi.org\/10.1080\/14767058.2018.1470235.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"495_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1177\/0300060517722698","volume":"46","author":"M Al-Lawama","year":"2018","unstructured":"Al-Lawama M, Alammori I, Abdelghani T, Badran E. Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus. J Int Med Res. 2018;46(2):811\u20138. https:\/\/doi.org\/10.1177\/0300060517722698.","journal-title":"J Int Med Res"},{"issue":"9","key":"495_CR18","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1080\/14767058.2018.1525354","volume":"33","author":"B Balachander","year":"2020","unstructured":"Balachander B, Mondal N, Bhat V, Adhisivam B, Kumar M, Satheesh S, Thulasingam M. Comparison of efficacy of oral paracetamol versus ibuprofen for PDA closure in preterms\u2014a prospective randomized clinical trial. J Matern Fetal Neonatal Med. 2020;33(9):1587\u201392. https:\/\/doi.org\/10.1080\/14767058.2018.1525354.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"495_CR19","doi-asserted-by":"publisher","DOI":"10.5812\/ijp.3975","author":"MM Bagheri","year":"2016","unstructured":"Bagheri MM, Niknafs P, Sabsevari F, Torabi MH, Bahman Bijari B, Noroozi E, Mossavi H. Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus. Iran J Pediatr. 2016. https:\/\/doi.org\/10.5812\/ijp.3975.","journal-title":"Iran J Pediatr"},{"issue":"11","key":"495_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077888","volume":"8","author":"D Dang","year":"2013","unstructured":"Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS ONE. 2013;8(11): e77888. https:\/\/doi.org\/10.1371\/journal.pone.0077888.","journal-title":"PLoS ONE"},{"issue":"7","key":"495_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13312-015-0677-z","volume":"52","author":"SK Dash","year":"2015","unstructured":"Dash SK, Kabra NS, Avasthi BS, Sharma SR, Padhi P, Ahmed J. Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: a randomized controlled trial. Indian Pediatr. 2015;52(7):573\u20138. https:\/\/doi.org\/10.1007\/s13312-015-0677-z.","journal-title":"Indian Pediatr"},{"issue":"2","key":"495_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00431-016-2830-7","volume":"176","author":"AE-R El-Mashad","year":"2017","unstructured":"El-Mashad AE-R, El-Mahdy H, El Amrousy D, Elgendy M. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr. 2017;176(2):233\u201340. https:\/\/doi.org\/10.1007\/s00431-016-2830-7.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"495_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/jrms.JRMS_631_17","volume":"24","author":"M Ghaderian","year":"2019","unstructured":"Ghaderian M, Armanian A, Sabri M, Montaseri M. Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates. J Res Med Sci. 2019;24(1):13. https:\/\/doi.org\/10.4103\/jrms.JRMS_631_17.","journal-title":"J Res Med Sci"},{"key":"495_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jpeds.2016.04.066","volume":"177","author":"P H\u00e4rkin","year":"2016","unstructured":"H\u00e4rkin P, H\u00e4rm\u00e4 A, Aikio O, Valkama M, Leskinen M, Saarela T, Hallman M. Paracetamol accelerates closure of the ductus arteriosus after premature birth: a randomized trial. J Pediatr. 2016;177:72-77.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2016.04.066.","journal-title":"J Pediatr"},{"key":"495_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/20469047.2018.1483566","author":"V Khuwuthyakorn","year":"2018","unstructured":"Khuwuthyakorn V, Jatuwattana C, Silvilairat S, Tantiprapha W. Oral indomethacin versus oral ibuprofen for treatment of patent ductus arteriosus: a randomised controlled study in very low-birthweight infants. Paediatr Int Child Health. 2018. https:\/\/doi.org\/10.1080\/20469047.2018.1483566.","journal-title":"Paediatr Int Child Health"},{"issue":"1","key":"495_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2017-000143","volume":"1","author":"A Kumar","year":"2017","unstructured":"Kumar A, Sundaram V, Yadav R, Oleti TP, Murki S, Krishna A, Sundaram M, Saini SS, Dutta S. Oral paracetamol versus oral ibuprofen for closure of haemodynamically significant patent ductus arteriosus in preterm neonates (<32 weeks): a blinded, randomised, active-controlled, non-inferiority trial. BMJ Paediatr Open. 2017;1(1): e000143. https:\/\/doi.org\/10.1136\/bmjpo-2017-000143.","journal-title":"BMJ Paediatr Open"},{"key":"495_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpeds.2020.01.058","volume":"222","author":"A Kumar","year":"2020","unstructured":"Kumar A, Gosavi RS, Sundaram V, Oleti TP, Krishnan A, Kiran S, Kumar J, Murki S, Sundaram M, Saini SS, Dutta S. Oral paracetamol vs oral ibuprofen in patent ductus arteriosus: a randomized, controlled, noninferiority trial. J Pediatr. 2020;222:79-84.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2020.01.058.","journal-title":"J Pediatr"},{"issue":"5","key":"495_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41372-019-0347-4","volume":"39","author":"M Liebowitz","year":"2019","unstructured":"Liebowitz M, Kaempf J, Erdeve O, Bulbul A, H\u00e5kansson S, Lindqvist J, Farooqi A, Katheria A, Sauberan J, Singh J, Nelson K, Wickremasinghe A, Dong L, Hassinger DC, Aucott SW, Hayashi M, Heuchan AM, Carey WA, Derrick M, Clyman RI, et al. Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (Nct01958320). J Perinatol. 2019;39(5):599\u2013607. https:\/\/doi.org\/10.1038\/s41372-019-0347-4.","journal-title":"J Perinatol"},{"issue":"3","key":"495_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000450822","volume":"111","author":"YJ Lin","year":"2017","unstructured":"Lin YJ, Chen CM, Rehan VK, Florens A, Wu SY, Tsai ML, Kuo YT, Huang FK, Yeh TF. Randomized trial to compare renal function and ductal response between indomethacin and ibuprofen treatment in extremely low birth weight infants. Neonatology. 2017;111(3):195\u2013202. https:\/\/doi.org\/10.1159\/000450822.","journal-title":"Neonatology"},{"issue":"3","key":"495_CR30","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jpeds.2013.11.008","volume":"164","author":"MY Oncel","year":"2014","unstructured":"Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, Canpolat FE, Dilmen U. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr. 2014;164(3):510-514.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2013.11.008.","journal-title":"J Pediatr"},{"issue":"4","key":"495_CR31","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3892\/etm.2016.3676","volume":"12","author":"B Yang","year":"2016","unstructured":"Yang B, Gao X, Ren Y, Wang Y, Zhang Q. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: a randomized controlled trial. Exp Ther Med. 2016;12(4):2531\u20136. https:\/\/doi.org\/10.3892\/etm.2016.3676.","journal-title":"Exp Ther Med"},{"issue":"4","key":"495_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/jrsm.1260","volume":"8","author":"R Suurmond","year":"2017","unstructured":"Suurmond R, van Rhee H, Hak T. Introduction, comparison, and validation of Meta-Essentials: A free and simple tool for meta-analysis. Res Synth Methods. 2017;8(4):537\u201353. https:\/\/doi.org\/10.1002\/jrsm.1260.","journal-title":"Res Synth Methods"},{"key":"495_CR33","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A, editors. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group. 2013."},{"issue":"5","key":"495_CR34","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s00246-014-0861-2","volume":"35","author":"S Yadav","year":"2014","unstructured":"Yadav S, Agarwal S, Maria A, Dudeja A, Dubey NK, Anand P, Yadav DK. Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial. Pediatr Cardiol. 2014;35(5):824\u201330. https:\/\/doi.org\/10.1007\/s00246-014-0861-2.","journal-title":"Pediatr Cardiol."},{"key":"495_CR35","unstructured":"Uptodate. (n.d.-a). https:\/\/www.uptodate.com\/contents\/acetaminophen-paracetamol-drug-information#F129302. Accessed 4 Aug 2021."},{"key":"495_CR36","unstructured":"Uptodate. (n.d.-b). https:\/\/www.uptodate.com\/contents\/indomethacin-drug-information#F182638. Accessed 4 Aug 2021."},{"key":"495_CR37","unstructured":"Uptodate. (n.d.-c). https:\/\/www.uptodate.com\/contents\/ibuprofen-druginformation#F181440. Accessed 4 Aug 2021."},{"issue":"1","key":"495_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12887-021-02600-8","volume":"21","author":"A Rolnitsky","year":"2021","unstructured":"Rolnitsky A, Urbach D, Unger S, Bell CM. Regional variation in cost of neonatal intensive care for extremely preterm infants. BMC Pediatr. 2021;21(1):134. https:\/\/doi.org\/10.1186\/s12887-021-02600-8.","journal-title":"BMC Pediatr"},{"issue":"2 Suppl","key":"495_CR39","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.7326\/M19-2415","volume":"172","author":"R Crowley","year":"2020","unstructured":"Crowley R, Daniel H, Cooney TG, Engel LS, Health and Public Policy Committee of the American College of Physicians. Envisioning a better U.S. Health care system for all: coverage and cost of care. Ann Intern Med. 2020;172(2 Suppl):S7\u201332. https:\/\/doi.org\/10.7326\/M19-2415.","journal-title":"Ann Intern Med"},{"issue":"7","key":"495_CR40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2217\/cer-2020-0235","volume":"10","author":"S Al-Shaibi","year":"2021","unstructured":"Al-Shaibi S, Abushanab D, Alhersh E, Kaddoura R, Pallivalappila AR, Al-Badriyeh D. Use of ibuprofen for the closure of patent ductus arteriosus in preterm infants: a systematic review of meta-analyses. J Comp Eff Res. 2021;10(7):549\u201368. https:\/\/doi.org\/10.2217\/cer-2020-0235.","journal-title":"J Comp Eff Res"},{"issue":"3","key":"495_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ihj.2020.05.012","volume":"72","author":"R Pranata","year":"2020","unstructured":"Pranata R, Yonas E, Vania R, Prakoso R. The efficacy and safety of oral paracetamol versus oral ibuprofen for patent ductus arteriosus closure in preterm neonates\u2014a systematic review and meta-analysis. Indian Heart J. 2020;72(3):151\u20139. https:\/\/doi.org\/10.1016\/j.ihj.2020.05.012.","journal-title":"Indian Heart J"},{"key":"495_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104418","volume":"148","author":"E Marconi","year":"2019","unstructured":"Marconi E, Bettiol A, Ambrosio G, Perduca V, Vannacci A, Troiani S, Dani C, Mugelli A, Lucenteforte E. Efficacy and safety of pharmacological treatments for patent ductus arteriosus closure: a systematic review and network meta-analysis of clinical trials and observational studies. Pharmacol Res. 2019;148: 104418. https:\/\/doi.org\/10.1016\/j.phrs.2019.104418.","journal-title":"Pharmacol Res"},{"key":"495_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpeds.2017.05.024","volume":"189","author":"GM Bixler","year":"2017","unstructured":"Bixler GM, Powers GC, Clark RH, Walker MW, Tolia VN. Changes in the diagnosis and management of patent ductus arteriosus from 2006 to 2015 in united states neonatal intensive care units. J Pediatr. 2017;189:105\u201312. https:\/\/doi.org\/10.1016\/j.jpeds.2017.05.024.","journal-title":"J Pediatr"},{"issue":"1","key":"495_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/chd.12708","volume":"14","author":"MN Sankar","year":"2019","unstructured":"Sankar MN, Bhombal S, Benitz WE. PDA: to treat or not to treat. Congenit Heart Dis. 2019;14(1):46\u201351. https:\/\/doi.org\/10.1111\/chd.12708.","journal-title":"Congenit Heart Dis"},{"key":"495_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.607772","volume":"8","author":"T Ibrahim","year":"2020","unstructured":"Ibrahim T, Abdul Haium AA, Tapawan SJ, Dela Puerta R, Allen JC, Chandran S, Chua MC, Rajadurai VS. Selective treatment of pda in high-risk vlbw infants with birth weight \u2264800 g or <27 weeks and short-term outcome: a cohort study. Front Pediatr. 2020;8: 607772. https:\/\/doi.org\/10.3389\/fped.2020.607772.","journal-title":"Front Pediatr"},{"key":"495_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.626262","volume":"9","author":"EJS Jansen","year":"2021","unstructured":"Jansen EJS, Hundscheid T, Onland W, Kooi EMW, Andriessen P, de Boode WP. Factors associated with benefit of treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Front Pediatr. 2021;9: 626262. https:\/\/doi.org\/10.3389\/fped.2021.626262.","journal-title":"Front Pediatr"},{"issue":"1","key":"495_CR47","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12887-018-1215-7","volume":"18","author":"T Hundscheid","year":"2018","unstructured":"Hundscheid T, Onland W, van Overmeire B, Dijk P, van Kaam AHLC, Dijkman KP, Kooi EMW, Villamor E, Kroon AA, Visser R, Vijlbrief DC, de Tollenaer SM, Cools F, van Laere D, Johansson A-B, Hocq C, Zecic A, Adang E, Donders R, de Boode WP, et al. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial). BMC Pediatr. 2018;18(1):262. https:\/\/doi.org\/10.1186\/s12887-018-1215-7.","journal-title":"BMC Pediatr"},{"issue":"5","key":"495_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050682","volume":"11","author":"S Mitra","year":"2021","unstructured":"Mitra S, Jain A, Ting JY, Ben Fadel N, Drolet C, Abou Mehrem A, Soraisham A, Jasani B, Louis D, Lapointe A, Dorling J, Khurshid F, Hyderi A, Kumaran K, Bodani J, Weisz D, Alvaro R, Adie M, Stavel M, Shah P, et al. Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (Pda) in preterm infants: a protocol for a multicentre comparative effectiveness study (Canrxpda). BMJ Open. 2021;11(5): e050682. https:\/\/doi.org\/10.1136\/bmjopen-2021-050682.","journal-title":"BMJ Open"},{"issue":"3","key":"495_CR49","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000515415","volume":"118","author":"T Schindler","year":"2021","unstructured":"Schindler T, et al. Early PARacetamol (EPAR) trial: a randomized controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants. Neonatology. 2021;118(3):274\u201381. https:\/\/doi.org\/10.1159\/000515415.","journal-title":"Neonatology"},{"key":"495_CR50","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3389\/fped.2020.00541","volume":"8","author":"JCA de Klerk","year":"2020","unstructured":"de Klerk JCA, et al. Spontaneous closure of the ductus arteriosus in preterm infants: a systematic review. Front Pediatr. 2020;8:541. https:\/\/doi.org\/10.3389\/fped.2020.00541.","journal-title":"Front Pediatr"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-022-00495-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-022-00495-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-022-00495-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T02:18:36Z","timestamp":1648001916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-022-00495-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["495"],"URL":"https:\/\/doi.org\/10.1007\/s40272-022-00495-1","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"31 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Ramesh Vidavalur declares that he has no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participate"}},{"value":"Signed.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"RV conceptualized the study, acquired and analyzed the data, and wrote the manuscript for submission.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}